tag financing 
Pharmaceutical Technology
FEBRUARY 10, 2023
This is not the first treatment to come with a high price tag. 79% of risk-sharing agreements are finance-based According to GlobalData’s risk-sharing database, over 1,000 RSAs were made in the last decade across 28 countries and roughly 100 companies.
World of DTC Marketing
FEBRUARY 19, 2021
NewsGuard found that 67% of the COVID misinformation sites had Google advertising tags and 30% had tags from The Trade Desk. An analysis of programmatic advertising data finds a disconnect between those well-intentioned efforts and the programmatic advertising campaigns that those same companies and institutions finance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
MARCH 8, 2023
It is worth noting that smart labels contain a transponder code which can be read by sophisticated devices, including radio frequency identification device (RFID) tags and near-field communication (NFC) chips. While most smartphones can read NFC chips, RFID tags can only be read by specialized receivers.
World of DTC Marketing
JUNE 23, 2021
Aduhelm is far from the first $55,000 flop put forth by the toxic American combination of a highly commodified pharmaceutical industry and disjointed financing stymied by private interests. Not to mention the $56,000 annual price tag. government. Without a total overhaul of this dysfunctional status quo, it won’t be the last.
pharmaphorum
JUNE 12, 2022
Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price. Beti-cel offers another potentially curative treatment for a much broader range of patients.
pharmaphorum
APRIL 14, 2022
million price tag. ” There’s a lot riding on the outcome of the beti-cel advisory committee meeting and FDA review, as bluebird revealed last month that its future as an ongoing business was uncertain unless it can raise additional financing. The post ICER says bluebird bio’s $2.1m
pharmaphorum
AUGUST 18, 2022
million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 There is a lot riding on the commercial success of Zynteglo, as bluebird revealed earlier this year that its future as an ongoing business was uncertain unless it can raise additional financing.
Expert insights. Personalized for you.
263 
Let's personalize your content